Comments
Loading...

Sarepta Therapeutics

SRPTNASDAQ
Logo brought to you by Benzinga Data
$125.01
-0.68-0.54%
At Close: -
$125.01
00.00%
After Hours: 4:53 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$235.00
Lowest Price Target1
$109.00
Consensus Price Target1
$185.39

Sarepta Therapeutics (NASDAQ:SRPT) Stock, Analyst Ratings, Price Targets, Forecasts

Sarepta Therapeutics Inc has a consensus price target of $185.39 based on the ratings of 23 analysts. The high is $235 issued by Needham on June 27, 2024. The low is $109 issued by Deutsche Bank on December 12, 2023. The 3 most-recent analyst ratings were released by RBC Capital on September 6, 2024, August 15, 2024, and August 8, 2024, respectively. With an average price target of $181 between RBC Capital, there's an implied 44.79% upside for Sarepta Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
3
1
May
9
2
Jun
2
Jul
5
2
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Citigroup
Cantor Fitzgerald
Piper Sandler
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for Sarepta Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Sarepta Therapeutics (SRPT) stock?

A

The latest price target for Sarepta Therapeutics (NASDAQ:SRPT) was reported by RBC Capital on September 6, 2024. The analyst firm set a price target for $181.00 expecting SRPT to rise to within 12 months (a possible 44.79% upside). 65 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Sarepta Therapeutics (SRPT)?

A

The latest analyst rating for Sarepta Therapeutics (NASDAQ:SRPT) was provided by RBC Capital, and Sarepta Therapeutics reiterated their outperform rating.

Q

When was the last upgrade for Sarepta Therapeutics (SRPT)?

A

The last upgrade for Sarepta Therapeutics Inc happened on August 8, 2024 when Evercore ISI Group raised their price target to $179. Evercore ISI Group previously had an in-line for Sarepta Therapeutics Inc.

Q

When was the last downgrade for Sarepta Therapeutics (SRPT)?

A

The last downgrade for Sarepta Therapeutics Inc happened on June 26, 2024 when Citigroup changed their price target from $172 to $176 for Sarepta Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Sarepta Therapeutics (SRPT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sarepta Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sarepta Therapeutics was filed on September 6, 2024 so you should expect the next rating to be made available sometime around September 6, 2025.

Q

Is the Analyst Rating Sarepta Therapeutics (SRPT) correct?

A

While ratings are subjective and will change, the latest Sarepta Therapeutics (SRPT) rating was a reiterated with a price target of $181.00 to $181.00. The current price Sarepta Therapeutics (SRPT) is trading at is $125.01, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch